PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p ...

Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today reported its financial ...

PARIS & BOSTON & SYDNEY--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) and Endotherapeutics, today announced that Cellvizio system has been included in the ...

PARIS & BOSTON, November 20, 2025--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal ...

Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces that it has ...

Results build on new CLIMB study data recently presented at Digestive Disease Week ® (DDW) 1 confirming Cellvizio ® ’s unmatched accuracy in pancreatic cyst diagnosis PARIS & BOSTON--(BUSINESS WIRE)-- ...

Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform and TaeWoong ...

MAUNA KEA, Hawai‘i (Island News) -- The Office of Hawaiian Affairs (OHA) decided to drop the lawsuits regarding the oversight of Mauna Kea. The litigation against the state, the Board of Land and ...

Recently approved safeguard proceeding yielding productive creditor and investor discussions aimed at strengthening Mauna Kea’s long-term financial position Currently in exclusive negotiations phase ...